查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018771

長讀長定序市場：按產品/服務、技術、應用和最終用戶分類的全球市場預測，2026-2032年

Long Read Sequencing Market by Product & Service, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，長讀定序市場價值將達到 10.9 億美元，到 2026 年將成長到 14 億美元，到 2032 年將達到 58.2 億美元，年複合成長率為 26.92%。

主要市場統計數據
基準年 2025 10.9億美元
預計年份：2026年 14億美元
預測年份 2032 58.2億美元
複合年成長率 (%) 26.92%

這篇簡潔而權威的介紹說明了長讀定序如何發展成為一個策略平台，重塑了研究、診斷和應用基因組學。

長讀長定定序已從一項專門的研究技術發展成為一個策略平台，重塑了基因組研究、臨床轉化流程和應用生命科學。這項技術能夠闡明複雜的基因組區域，確定長單倍型中等位基因的相位，並檢測天然分子中的結構變異和表觀遺傳標記，從而開闢了短讀長測序方法無法充分應用的領域。因此，研究機構、診斷實驗室和產業應用者正在重新思考他們的技術架構、工作流程和供應商關係，以最大限度地發揮長讀長定序的科學和營運優勢。

從技術、商業性和工作流程變革的角度展望未來，這些變革正在重新定義整個產業中長讀定定序的採用和營運模式。

長讀長定序領域正經歷一場變革，其驅動力包括技術的成熟、工作流程的整合以及終端使用者需求的不斷變化。硬體和化學技術的進步提高了逐讀測序的準確性和運行穩定性。模組化的儀器架構實現了可擴展的通量，從桌上型部署到高容量中心均可適用。同時，即時鹼基編碼和天然表觀遺傳檢測技術的出現，催生了新的應用場景，在這些場景中，快速週轉和多層次的分子資訊至關重要。

對美國到 2025 年的累積關稅措施如何重塑定序系統中的籌資策略、供應韌性和供應商應對措施進行了深入分析。

美國計劃在2025年前實施累積關稅措施，這給整個長讀長定序系統的採購、供應鏈韌性和籌資策略帶來了新的挑戰。進口設備和關鍵試劑關稅的提高迫使各機構重新評估供應商關係和前置作業時間風險。為此，許多相關人員正在優先考慮供應商多元化，確保流動池和專用試劑盒等關鍵耗材的緩衝庫存，並審查服務合約以確保價格和交貨時間的合理性。

對產品、技術、應用和最終用戶等各個維度上的細微細分趨勢進行詳細分析，為策略優先排序提供指南。

細分市場層面的趨勢揭示了每種產品/服務、技術、應用和最終用戶群體的不同促進因素，而這些差異對於策略定位至關重要。在產品和服務細分中，來自流動池、試劑盒和試劑等耗材的持續收入仍然是營運的核心考慮因素，因為耗材的可靠性和連續性直接影響通量和實驗可重複性。對定序系統及相關配件的投資決定了資本規劃週期，而生物資訊服務、數據分析軟體和維護服務則決定了長期營運支援和合規準備。

從區域比較情報的觀點出發，分析全球主要區域的採用促進因素、法律規範和商業生態系統的差異。

區域趨勢反映了研究基礎設施、法規環境和商業生態系統的差異，從而以不同的方式塑造了技術應用路徑和競爭重點。在美洲，強大的學術研究網路、高度集中的臨床試驗活動以及成熟的供應商基礎正在加速高精度長讀長定序技術在腫瘤學、神經基因組學和微生物監測領域的應用。該地區還擁有成熟的公私合營模式，將定序整合到公共衛生舉措和轉化項目中。

對企業發展趨勢進行策略性回顧，展示平台創新、整合服務和不斷演進的經營模式如何創造競爭優勢。

長讀長定序領域的企業策略正朝著幾個通用的主題發展：提昇平台效能、管理耗材生命週期、整合軟體和服務以及促進合作夥伴關係。領先的儀器供應商正投資於化學創新和孔徑設計，以降低誤差率並提高通量，同時也在擴展儀器外形規格，以適應更廣泛的實驗室安裝空間。除了硬體的進步，各公司還在加速開發分析套件和託管服務，以消除臨床和工業用戶在需要檢驗的端到端工作流程時遇到的障礙。

為平衡供應鏈韌性、生物資訊投資、與監管機構合作以及以客戶為中心的經營模式，提出切實可行的建議。

產業領導者應採取組合策略，兼顧短期業務永續營運和長期策略差異化。首先，應透過建立關鍵耗材（例如流動池和特種試劑）的多源採購策略來增強供應鏈韌性，並在適當情況下簽訂多年期契約，同時評估區域分銷和組裝方案，以減輕跨境關稅波動的影響。其次，應優先投資於生物資訊學和數據管理。標準化、檢驗的流程和健全的資料管治能夠加速臨床部署並支援機構間合作。

對用於整合與技術趨勢、相關人員觀點和市場區隔一致的見解的實證分析過程進行透明的解釋。

本執行摘要的研究結合了結構化的二手資料分析、專家訪談和多來源檢驗，以確保其嚴謹性和相關性。二手資料分析包括對同行評審文獻、專利趨勢、已發布的產品公告、監管文件和技術白皮書的系統性回顧，揭示了技術發展軌跡和創新熱點。這些資訊來源被整合起來，用於識別新興的績效基準、工作流程轉變和經營模式創新。

摘要闡明了為最大限度地發揮長讀定序創新價值所必需的策略挑戰和營運重點。

長讀長定序正處於一個轉折點，技術進步、應用拓展和商業實踐的演進正在為研究機構、臨床檢查室和商業生命科學組織創造持久的策略價值。長讀長定序能夠提供長程基因組資訊、原生檢測表觀遺傳標記並揭示結構複雜性，進而推動腫瘤學、微生物監測、農業育種和轉化研究等領域的進步。結合對檢驗的分析方法和穩健供應鏈的投資，這些技術優勢將轉化為實際的營運和策略效益。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：長讀長定序市場：依產品和服務分類

  • 消耗品
    • 流動池
    • 成套工具
    • 試劑
  • 裝置
    • 配件
    • 定序系統
  • 軟體服務
    • 生物資訊服務
    • 數據分析軟體
    • 維護服務

第9章：長讀長定序市場：依技術分類

  • 奈米孔定序
  • 單分子即時定序
  • 合成長讀定序

第10章：長讀長定序市場：依應用領域分類

  • 農業基因組學
  • 癌症基因體學
  • 臨床研究
  • 微生物基因體學

第11章：長讀長定序市場：依最終用戶分類

  • 學術機構
  • 臨床診斷檢查室
  • 合約研究機構
  • 政府和監管機構
  • 製藥和生物技術

第12章：長讀長定序市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：長讀長定序市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：長讀長定序市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國長讀長定序市場

第16章：中國長讀長定序市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arima Genomics, Inc.
  • BGI Genomics Co., Ltd.
  • Dovetail Genomics, LLC
  • Element Biosciences, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genapsys, Inc.
  • Hitachi High-Technologies Corporation
  • Illumina, Inc.
  • Nabsys, Inc.
  • Nuclera Nucleics Ltd.
  • Oxford Nanopore Technologies Limited
  • Pacific Biosciences of California, Inc.
  • Phase Genomics, Inc.
  • QIAGEN NV
  • Quantapore, Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-A26E0E574570

The Long Read Sequencing Market was valued at USD 1.09 billion in 2025 and is projected to grow to USD 1.40 billion in 2026, with a CAGR of 26.92%, reaching USD 5.82 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.09 billion
Estimated Year [2026] USD 1.40 billion
Forecast Year [2032] USD 5.82 billion
CAGR (%) 26.92%

A concise and authoritative introduction explaining how long read sequencing has evolved into a strategic platform reshaping research, diagnostics, and applied genomics

Long read sequencing has moved from a specialized research capability into a strategic platform that is reshaping genomics research, clinical translational pipelines, and applied life sciences. The technology's ability to resolve complex genomic regions, phase alleles across long haplotypes, and detect structural variants and epigenetic marks in native molecules has unlocked applications that short-read methods cannot reliably address. As a result, research institutions, diagnostic labs, and industry adopters are re-evaluating technology stacks, workflows, and vendor relationships to capture the scientific and operational advantages offered by long reads.

In parallel, advances in chemistry, pore engineering, instrument design, and bioinformatics have increased read accuracy and throughput while simplifying sample preparation. These technical improvements, together with greater accessibility of analysis tools and cloud-enabled workflows, have lowered barriers to entry and broadened the user base beyond specialist sequencing centers. Consequently, organizations are moving from proof-of-concept studies to routine incorporation of long reads within programs in oncology, pathogen surveillance, crop improvement, and precision medicine.

Transitioning from experimental use to production-grade operations requires attention to reproducibility, regulatory readiness, and supply continuity. Institutions seeking to capitalize on long-read capability must therefore integrate robust data management, validation practices, and vendor-agnostic quality controls to ensure that the scientific gains translate into operational impact and credible clinical or regulatory outputs.

A forward-looking exploration of the technological, commercial, and workflow shifts that are redefining long read sequencing adoption and operational models across sectors

The landscape of long read sequencing is undergoing transformative shifts driven by technological maturation, workflow integration, and evolving end-user expectations. Hardware and chemistry advances have improved per-read accuracy and extended run stability, while modular instrument architectures permit scalable throughput from benchtop deployments to high-capacity centers. At the same time, real-time basecalling and native epigenetic detection have enabled new use cases where rapid turnaround and multi-layered molecular information are essential.

Concurrently, software ecosystems have shifted from bespoke academic scripts to enterprise-grade solutions that emphasize reproducibility, reproducible pipelines, and regulatory compliance. Cloud-native analysis frameworks, containerization, and standardized APIs are enabling cross-platform interoperability and easing barriers for clinical laboratories and CROs to adopt long-read workflows. Moreover, the commoditization of consumables and focus on sustainability in reagent manufacturing are influencing procurement strategies and long-term operating costs.

These changes are also manifesting in market behavior: vendors are diversifying commercial models to include instrument-as-a-service, subscription-based consumable plans, and integrated service offerings that bundle sequencing with bioinformatics and maintenance. As organizations reconsider long-term investments, attention is shifting toward total cost of ownership, lifecycle support, and the ability of technology partners to deliver validated workflows that meet regulatory and clinical-grade requirements.

An incisive assessment of how cumulative U.S. tariff measures through 2025 have reshaped procurement strategies, supply resilience, and vendor responses in the sequencing ecosystem

The cumulative tariff measures introduced in the United States through 2025 have introduced new dimensions to procurement, supply chain resilience, and sourcing strategies across the long read sequencing ecosystem. Increased duties on imported instruments and key reagents have prompted organizations to reassess vendor relationships and inventory policies to mitigate cost volatility and lead-time risk. In response, many stakeholders have prioritized diversification of suppliers, established buffer inventories for critical consumables like flow cells and specialized kits, and re-evaluated service contracts to lock in pricing and delivery windows.

Manufacturers and distributors have adapted by exploring onshore assembly, regional distribution centers, and partnerships with local manufacturers to reduce exposure to cross-border tariff impacts. For customers, the tariff environment has made lifecycle planning more complex: procurement cycles are extending as purchasers perform more thorough total-cost analyses and seek multi-year service agreements to manage post-tariff operating budgets. At the same time, some vendors have absorbed a portion of increased costs through pricing strategies that preserve installed-base loyalty, while others have accelerated investments in regional manufacturing to regain competitive positioning and shorten supply lines.

Overall, tariffs have emphasized the strategic value of supply-chain transparency, contractual flexibilities, and scenario planning. Organizations that proactively model tariff exposures, negotiate flexible terms, and develop alternative sourcing strategies are better positioned to sustain research continuity, protect clinical workflows, and maintain competitive timelines for product development and discovery.

A deep-dive synthesis of nuanced segmentation dynamics across product, technology, application, and end-user dimensions that inform strategic prioritization

Segment-level dynamics reveal differentiated drivers across products and services, technologies, applications, and end-user groups, and these distinctions are critical for strategic positioning. Within product and service segmentation, recurring revenue from consumables-including flow cells, kits, and reagents-remains a central operational consideration because consumable reliability and supply continuity directly affect throughput and experimental reproducibility. Investments in sequencing systems and supporting accessories shape capital planning cycles, whereas bioinformatics services, data analysis software, and maintenance services determine long-term operational support and regulatory readiness.

Across technology segmentation, nanopore sequencing has matured as a highly portable, real-time solution suited to field deployments and rapid surveillance, while single molecule real time sequencing has strengthened its niche where high per-read accuracy and circular consensus approaches are essential. Synthetic long read strategies continue to provide cost-effective alternatives for certain assembly tasks and large-genome projects where reconstructing long-range information from linked reads remains advantageous.

In terms of application, agricultural genomics benefits from long reads for structural variant detection and complex trait mapping, cancer genomics uses long-range phasing to resolve tumor heterogeneity, clinical research leverages comprehensive variant calling for translational studies, and microbial genomics relies on long reads for plasmid resolution and outbreak tracing. End users differ in priorities: academic centers focus on methodological innovation and novel use cases, clinical diagnostic laboratories emphasize validation, throughput, and compliance, contract research organizations offer turnkey sequencing services for multiple clients, government and regulatory bodies concentrate on surveillance and standardization, and pharmaceutical and biotechnology firms integrate long reads into target discovery and biomarker validation workflows.

A comparative regional intelligence perspective capturing how adoption drivers, regulatory frameworks, and commercial ecosystems diverge across major global regions

Regional dynamics are shaping adoption pathways and competitive priorities in distinct ways, reflecting differences in research infrastructure, regulatory environments, and commercial ecosystems. In the Americas, strong academic research networks, a dense concentration of clinical trial activity, and established vendor bases have accelerated adoption of high-accuracy long-read pipelines for oncology, neurogenomics, and microbial surveillance. This region also demonstrates mature public-private collaboration models that integrate sequencing into public health initiatives and translational programs.

In Europe, the Middle East & Africa, regulatory harmonization efforts and pan-European consortia are driving coordinated investments in reference genomes, surveillance networks, and cross-border data sharing. Research funding models in this region often emphasize collaborative infrastructure and standardized protocols, which in turn influence procurement cycles and demand for validated workflows and compliance-ready software. The presence of multiple language markets and diverse healthcare systems increases the importance of localized support and multi-jurisdictional regulatory expertise.

In the Asia-Pacific region, rapid capital deployment, expanding domestic manufacturing capabilities, and intensive activity in agricultural genomics and infectious disease surveillance have accelerated both adoption and innovation. Regional players often prioritize scalable platforms that balance throughput with cost-efficiency, and cross-border collaborations within the region are fostering ecosystem growth. Together, these regional distinctions inform go-to-market approaches, partnership models, and where to focus investments in local support and supply-chain resilience.

A strategic review of corporate behaviors showing how platform innovation, integrated services, and commercial model evolution are shaping competitive advantage

Corporate strategies within the long read sequencing domain are converging around several consistent themes: platform performance improvements, consumable lifecycle management, software and service integration, and collaborative partnerships. Leading instrument vendors are investing in chemistry innovations and pore design to reduce error profiles and improve throughput while expanding instrument form factors to address a broader range of laboratory footprints. Complementary to hardware advances, companies are accelerating development of analysis suites and managed services to remove barriers for clinical and industrial users who require validated, end-to-end workflows.

At the same time, commercial models are becoming more flexible. Subscription-based access to instruments, reagent bundling, and comprehensive support packages are emerging as viable alternatives to traditional capital purchase models. Strategic partnerships-spanning reagent manufacturers, cloud analytics providers, and academic consortia-are being used to extend addressable markets and accelerate application-specific validation, for example in oncology panels, crop genomics pipelines, and pathogen surveillance protocols. Service providers and CROs are expanding capabilities to include long-read-specific offerings, enabling customers to outsource sequencing and analysis while preserving data governance and quality.

Finally, companies are prioritizing supply-chain diversification and regional manufacturing to mitigate tariff exposure and logistics risk. Those that combine robust R&D roadmaps with transparent service level agreements and localized support infrastructures are increasingly attractive to large institutional buyers and enterprise customers seeking long-term partnerships.

Practical and actionable recommendations that balance supply resilience, bioinformatics investment, regulatory engagement, and customer-centric commercial models

Industry leaders should pursue a portfolio approach that balances near-term operational continuity with long-term strategic differentiation. First, strengthen supply-chain resilience by establishing multi-sourcing strategies for critical consumables such as flow cells and specialized reagents, negotiating multi-year commitments where appropriate, and evaluating regional distribution or assembly options to reduce exposure to cross-border tariff volatility. Second, prioritize investments in bioinformatics and data management: standardized, validated pipelines and robust data governance accelerate clinical adoption and support cross-institutional collaborations.

Third, align product and commercial models with distinct end-user needs by offering flexible procurement options for academic laboratories, validated turnkey solutions for clinical diagnostic customers, and scalable service packages for contract research organizations. Fourth, engage proactively with regulatory stakeholders and participate in standards-setting initiatives to ensure that new workflows meet evolving compliance expectations and to reduce time-to-validation for clinical applications. Fifth, invest in training and field support to lower adoption friction; hands-on education for laboratory staff and translational scientists will increase throughput and reduce error rates.

Taken together, these actions will enable organizations to capitalize on scientific advantages, secure operational continuity, and convert technical leadership into measurable outcomes for research programs, clinical services, and product development pipelines.

A transparent explanation of the evidence base and analytic processes used to synthesize technical trends, stakeholder perspectives, and segmentation-aligned insights

The research underpinning this executive summary combines structured secondary analysis, expert interviews, and cross-source validation to ensure rigor and relevance. Secondary analysis included a systematic review of peer-reviewed literature, patent activity, public product announcements, regulatory filings, and technical white papers to map technology trajectories and innovation hotspots. These sources were synthesized to identify emerging performance benchmarks, workflow shifts, and commercial model innovations.

Complementing the literature review, qualitative interviews were conducted with laboratory directors, technology adopters, procurement leads, and industry strategists to ground technical trends in operational realities and procurement constraints. Interview insights informed interpretations of vendor strategies, customer pain points, and the practical implications of tariff-driven supply-chain changes. Findings were triangulated across sources to reduce bias and confirm recurring themes.

Finally, segmentation frameworks were applied to align insights with product categories, technology types, application domains, and end-user profiles. Limitations include the evolving nature of instrument performance claims and potential lag in public disclosures for proprietary developments; accordingly, the methodology emphasizes transparency about assumptions and recommends follow-up validation for investment decisions or procurement commitments.

A concluding synthesis that clarifies the strategic imperatives and operational priorities required to capture the full value of long read sequencing innovations

Long read sequencing stands at an inflection point where technical progress, expanding application breadth, and evolving commercial practices are creating sustained strategic value for research institutions, clinical laboratories, and commercial life-science organizations. The capacity to deliver long-range genomic information, detect epigenetic marks natively, and resolve structural complexity is catalyzing advancements in oncology, microbial surveillance, agricultural breeding, and translational research. When combined with investments in validated analytics and resilient supply chains, these technical strengths translate into tangible operational and strategic benefits.

However, realizing this potential requires deliberate actions: prioritizing validated workflows for regulated settings, building redundancies in consumable sourcing, and investing in software and services that ensure reproducibility and regulatory compliance. Stakeholders that align procurement, R&D planning, and partnership strategies with these imperatives will be best positioned to extract sustained value. In contrast, organizations that delay integration of long-read data into their pipelines risk falling behind in capabilities that increasingly define competitive research and clinical programs.

Ultimately, the trajectory of long read sequencing will continue to be shaped by innovations in chemistry and informatics, by the adaptability of commercial models, and by the ability of users and vendors to collaborate on standards, validation, and training that underpin broad, reliable adoption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Long Read Sequencing Market, by Product & Service

  • 8.1. Consumables
    • 8.1.1. Flow Cells
    • 8.1.2. Kits
    • 8.1.3. Reagents
  • 8.2. Instruments
    • 8.2.1. Accessories
    • 8.2.2. Sequencing Systems
  • 8.3. Software & Services
    • 8.3.1. Bioinformatics Services
    • 8.3.2. Data Analysis Software
    • 8.3.3. Maintenance Services

9. Long Read Sequencing Market, by Technology

  • 9.1. Nanopore Sequencing
  • 9.2. Single Molecule Real Time Sequencing
  • 9.3. Synthetic Long Read Sequencing

10. Long Read Sequencing Market, by Application

  • 10.1. Agricultural Genomics
  • 10.2. Cancer Genomics
  • 10.3. Clinical Research
  • 10.4. Microbial Genomics

11. Long Read Sequencing Market, by End User

  • 11.1. Academic
  • 11.2. Clinical Diagnostic Laboratories
  • 11.3. Contract Research Organizations
  • 11.4. Government And Regulatory Bodies
  • 11.5. Pharmaceutical And Biotechnology

12. Long Read Sequencing Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Long Read Sequencing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Long Read Sequencing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Long Read Sequencing Market

16. China Long Read Sequencing Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arima Genomics, Inc.
  • 17.6. BGI Genomics Co., Ltd.
  • 17.7. Dovetail Genomics, LLC
  • 17.8. Element Biosciences, Inc.
  • 17.9. F. Hoffmann-La Roche Ltd.
  • 17.10. Genapsys, Inc.
  • 17.11. Hitachi High-Technologies Corporation
  • 17.12. Illumina, Inc.
  • 17.13. Nabsys, Inc.
  • 17.14. Nuclera Nucleics Ltd.
  • 17.15. Oxford Nanopore Technologies Limited
  • 17.16. Pacific Biosciences of California, Inc.
  • 17.17. Phase Genomics, Inc.
  • 17.18. QIAGEN N.V.
  • 17.19. Quantapore, Inc.
  • 17.20. Takara Bio Inc.
  • 17.21. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LONG READ SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL LONG READ SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY FLOW CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SEQUENCING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY BIOINFORMATICS SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SINGLE MOLECULE REAL TIME SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY SYNTHETIC LONG READ SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY AGRICULTURAL GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CANCER GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY MICROBIAL GENOMICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY ACADEMIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GOVERNMENT AND REGULATORY BODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. GCC LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 154. GCC LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 155. GCC LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 156. GCC LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 157. GCC LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. GCC LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GCC LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. G7 LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 178. G7 LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 179. G7 LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 180. G7 LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 181. G7 LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. G7 LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. G7 LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. NATO LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 186. NATO LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 187. NATO LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 188. NATO LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 189. NATO LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. NATO LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL LONG READ SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA LONG READ SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA LONG READ SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA LONG READ SEQUENCING MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA LONG READ SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA LONG READ SEQUENCING MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA LONG READ SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA LONG READ SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA LONG READ SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)